ArticleCancers2021

Pre-Treatment Neutrophil-to-Lymphocyte Ratio (NLR) as a Predictive Marker of Pazopanib Treatment for Soft-Tissue Sarcoma.

Yasuyoshi Sato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.